Latest Vet-Stem Stories
BOCA RATON, Fla., Jan. 21 /PRNewswire-FirstCall/ -- Stem Cell Assurance, Inc. (PK: SCLZ) and MDwerks, Inc.
WAYNE, Pa., Jan. 8 /PRNewswire/ -- Six new stem cell therapies, all forecast to reach physicians in 2010, will be featured at the 5th Annual Stem Cell Summit on February 16 in New York City.
AUSTIN, Texas, Nov. 9 /PRNewswire/ -- Celling Technologies, a subsidiary of SpineSmith Partners, is collaborating with Tissue Genesis, Inc. to research potential applications for adipose tissue derived adult stem cells.
WAYNE, Pa., Sept. 23 /PRNewswire/ -- RRY Publications announced the preliminary lineup of presenters for the 5th Annual Stem Cell Summit, the premier gathering of stem cell company executives, scientists and investors to focus on the commercialization of stem cell products.
License Strengthens NeoStem's Portfolio of Regenerative Treatments NEW YORK, May 11, /PRNewswire-FirstCall/ -- NeoStem, Inc.
A new procedure that uses stem cells obtained from fat is providing relief for pets suffering from the aches and pains of arthritis and other ailments.
PHILADELPHIA, Jan. 7 /PRNewswire/ -- RRY Publications announced that the 4th Annual Stem Cell Summit, the premier gathering of stem cell company executives, scientists and investors, will focus on commercialization of stem cell therapies.
Celprogen Inc., a Global leader in the Stem Cell Research and Therapeutics industry for development of stem cell technologies in regenerative medicine, today announced that they have successfully validated shipment of embryonic and adult stem cells at room temperature within United States research facilities for in vivo applications.
Research and Markets (http://www.researchandmarkets.com/research/e43fbd/stem_cells_in_rege) has announced the addition of the "Stem Cells in Regenerative Medicine 2008 Market Report" report to their offering. This is the latest and most up-to-date Worldwide Stem Cells Market Report.
PHILADELPHIA, Aug. 12 /PRNewswire/ -- RRY Publications today announced the preliminary lineup of presenters for the 4th Annual Stem Cell Summit, the premier gathering of stem cell company executives, scientists and investors to focus on the commercialization of stem cell products.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.